Vident Investment Advisory’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-19,077
| Closed | -$1.79M | – | 360 |
|
|
2023
Q2 | $1.79M | Buy |
19,077
+3,449
| +22% | +$324K | 0.06% | 335 |
|
|
2023
Q1 | $1.06M | Buy |
15,628
+5,133
| +49% | +$348K | 0.03% | 510 |
|
|
2022
Q4 | $520K | Buy |
+10,495
| New | +$520K | 0.02% | 704 |
|
|
2022
Q3 | – | Sell |
-14,384
| Closed | -$565K | – | 1176 |
|
|
2022
Q2 | $565K | Sell |
14,384
-1,028
| -7% | -$40.4K | 0.02% | 836 |
|
|
2022
Q1 | $1.08M | Buy |
15,412
+53
| +0.3% | +$3.7K | 0.03% | 669 |
|
|
2021
Q4 | $1.2M | Sell |
15,359
-4,010
| -21% | -$312K | 0.03% | 639 |
|
|
2021
Q3 | $1.85M | Buy |
19,369
+5,033
| +35% | +$480K | 0.06% | 459 |
|
|
2021
Q2 | $1.78M | Buy |
14,336
+1,424
| +11% | +$177K | 0.05% | 455 |
|
|
2021
Q1 | $1.7M | Buy |
12,912
+3,705
| +40% | +$488K | 0.06% | 441 |
|
|
2020
Q4 | $1.22M | Buy |
9,207
+4,599
| +100% | +$609K | 0.05% | 484 |
|
|
2020
Q3 | $470K | Buy |
4,608
+577
| +14% | +$58.9K | 0.02% | 680 |
|
|
2020
Q2 | $351K | Buy |
+4,031
| New | +$351K | 0.02% | 738 |
|
|
2019
Q3 | – | Sell |
-3,731
| Closed | -$440K | – | 455 |
|
|
2019
Q2 | $440K | Sell |
3,731
-1,746
| -32% | -$206K | 0.04% | 360 |
|
|
2019
Q1 | $474K | Sell |
5,477
-1,569
| -22% | -$136K | 0.03% | 585 |
|
|
2018
Q4 | $445K | Sell |
7,046
-168
| -2% | -$10.6K | 0.02% | 617 |
|
|
2018
Q3 | $569K | Buy |
7,214
+1,818
| +34% | +$143K | 0.02% | 646 |
|
|
2018
Q2 | $323K | Buy |
5,396
+412
| +8% | +$24.7K | 0.01% | 791 |
|
|
2018
Q1 | $224K | Buy |
+4,984
| New | +$224K | 0.01% | 836 |
|